VT News
Kid Ink

Kid Ink

Ask VT AI
View News Summary
  • Arsenal close to signing Crystal Palace's Eberechi Eze as Palace's Europa League demotion puts financial pressure on the club.
  • Novartis' drug ianalumab meets Phase III endpoints in Sjögren's disease trials, potentially offering the first targeted therapy for this chronic autoimmune disorder.
  • Elon Musk threatens lawsuit against Apple over alleged antitrust favoritism of OpenAI's ChatGPT in the App Store.
5 days
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Latest News
Ask VT AI
View News Summary
  • Arsenal close to signing Crystal Palace's Eberechi Eze as Palace's Europa League demotion puts financial pressure on the club.
  • Novartis' drug ianalumab meets Phase III endpoints in Sjögren's disease trials, potentially offering the first targeted therapy for this chronic autoimmune disorder.
  • Elon Musk threatens lawsuit against Apple over alleged antitrust favoritism of OpenAI's ChatGPT in the App Store.
5 days
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from Kid Ink

Top Topics

Trending in U.S.

World

Sport